Otter Tail Corp Misses Earnings and Revenue Estimates in Latest Quarter
Otter Tail Corporation reported quarterly results that fell short of Wall Street expectations on both earnings per share and revenue.
Otter Tail Corporation reported quarterly results that fell short of Wall Street expectations on both earnings per share and revenue.
Heavy selling in AI-linked favorites has flipped the script, with heavily shorted stocks now beating Wall Street's top picks.
Robust iPhone demand isn't enough to lift Apple shares as a memory crunch and slowing services weigh on sentiment.
Investors in both Marvell and Lumentum pushed back sharply against the proposed all-stock acquisition, sending shares of each company lower Monday.
The Nasdaq-100 has entered its third correction of the year as worries about artificial intelligence valuations weigh on tech stocks.
Five months of sideways trading have pushed S&P 500 forward P/E below long-term averages, raising fresh debate over whether stocks are now attractively priced.
Mounting pressure on French sovereign debt is drawing attention from global markets as a cautionary tale about fiscal discipline.
Cybersecurity firm Okta is scheduled to enter the S&P 500 on Wednesday, taking the spot vacated by consumer-health spinoff Kenvue.
The SEC issued exemptive relief easing central clearing requirements for inter-affiliate and non-U.S. repo transactions involving Treasury securities.
A sharp Friday selloff in tech stocks has analysts drawing uncomfortable parallels to the dot-com bubble's collapse 25 years ago.
Big Tech dragged on headlines but most S&P 500 stocks finished October in positive territory, revealing underlying market resilience.
The SEC issued exemptive relief easing central clearing requirements for inter-affiliate and non-U.S. repo transactions involving Treasury securities.
Intel's latest results exposed supply constraints in AI server chips and a soft PC market, raising concern AMD faces similar headwinds.
Alliant Energy posted stronger-than-expected earnings while revenue aligned with analyst forecasts, signaling steady operational performance.
Aspen Neuroscience has priced its initial public offering at $15 per share, marking the company's entry into public markets.
One concise briefing, weekly. No spam.
By subscribing you agree to receive periodic communications. Unsubscribe anytime via the link in each message or our Unsubscribe page.